What changed
$WSM — AVOID 📊 | 6 MONTHS THESIS
🧭 Conviction: HIGH
🎯 FQ1 FY2027 (ends May) | reported May 21 | Rev $1.8B | EPS $1.93 vs $1.80 🟢 | Margin 16.2%
💡 Consensus models a steady growth trajectory, but the market already prices in perfection with a 31x multiple; the beat was modest and lacks follow-through metrics like FCF growth or operating leverage expansion, so expectations are likely too high, not too low.
🏢 Business Quality: 4/10
📊 Valuation: rich — 31x P/E vs discretionary sector median ~18x; EV/EBITDA likely >50x; FCF yield 0.4% provides no cash return; DCF at 10% WACC and 5% terminal...
🔮 Catalyst: Next quarterly earnings release (estimated August 2026)
⚖️ Avoid: Trades at 31x earnings with a 0.4% FCF yield and ranks in the bottom 1% of consumer discretionary stocks by our quantitative model; the EPS beat is insufficient to justify the rich valuation, and the risk/reward is unattractive for a 6-month long.